{"id":96912,"date":"2026-07-17T05:17:44","date_gmt":"2026-07-17T09:17:44","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/india-clears-wegovy-for-fatty-liver-disease-treatment\/"},"modified":"2026-07-17T05:17:44","modified_gmt":"2026-07-17T09:17:44","slug":"india-clears-wegovy-for-fatty-liver-disease-treatment","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/india-clears-wegovy-for-fatty-liver-disease-treatment\/","title":{"rendered":"India Clears Wegovy for Fatty Liver Disease Treatment"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"450\" height=\"300\" src=\"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/07\/news-1784279864169.jpg?resize=450%2C300&#038;ssl=1\" alt=\"\" class=\"wp-image-96911\" srcset=\"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/07\/news-1784279864169.jpg?w=450&amp;ssl=1 450w, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/07\/news-1784279864169.jpg?resize=300%2C200&amp;ssl=1 300w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/figure>\n\n\n<p>Danish drugmaker Novo Nordisk announced Friday that India&#8217;s national drug regulatory authority has granted approval for its popular obesity medication Wegovy to be used in treating metabolic dysfunction-associated steatohepatitis \u2014 commonly referred to as MASH \u2014 a severe form of fatty liver disease.<\/p><p>The Central Drugs Standard Control Organisation gave the go-ahead for Wegovy&#8217;s 2.4 mg semaglutide injection specifically for MASH treatment, according to the company.<\/p><p>MASH develops when excess fat accumulates in the liver, triggering inflammation and causing liver damage. The condition falls within a wider category of fatty liver diseases and can worsen into more serious liver complications when left without treatment.<\/p><p>Novo Nordisk pointed out that approximately two out of every three people in India live with fatty liver disease, underscoring the enormous number of potential patients in the country who could benefit from the newly approved treatment.<\/p><p>The company also noted that MASH is often considered a silent disease \u2014 meaning most patients experience no noticeable symptoms until the condition has already reached an advanced stage.<\/p><p>Wegovy, which has become one of Novo Nordisk&#8217;s most high-profile medications, uses the active ingredient semaglutide and already carries approval in India and several other markets for long-term weight management.<\/p><p>The company faces stiff competition in India&#8217;s rapidly expanding obesity drug market, going up against Eli Lilly&#8217;s Mounjaro as well as lower-priced generic semaglutide products introduced by homegrown pharmaceutical firms including Dr Reddy&#8217;s and Sun Pharma.<\/p><p>Sales data from market research firm Pharmarack show Novo Nordisk moved approximately 76,000 units of Wegovy in India during the first half of 2026.<\/p>","protected":false},"excerpt":{"rendered":"<p>Danish pharmaceutical company Novo Nordisk announced that India&#8217;s drug regulatory authority has given the green light to its obesity medication Wegovy for treating a serious form of fatty liver disease. The approval covers the drug&#8217;s 2.4 mg semaglutide injection for metabolic dysfunction-associated steatohepatitis, known as MASH. The company notes that roughly two out of three people in India are affected by fatty liver disease.<\/p>\n","protected":false},"author":4,"featured_media":96911,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[837],"tags":[],"class_list":["post-96912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/07\/news-1784279864169.jpg?fit=450%2C300&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-pd6","jetpack-related-posts":[{"id":39547,"url":"https:\/\/tvdelmarva.com\/wp\/fda-clears-increased-wegovy-dosage-for-weight-management\/","url_meta":{"origin":96912,"position":0},"title":"FDA Clears Increased Wegovy Dosage for Weight Management","author":"Admin","date":"March 19, 2026","format":false,"excerpt":"The Food and Drug Administration has given the green light to a stronger version of the weight loss medication Wegovy. Danish pharmaceutical company Novo Nordisk announced the approval on Thursday for long-term weight management.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1773937430833.jpg?fit=450%2C296&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":45049,"url":"https:\/\/tvdelmarva.com\/wp\/wegovy-maker-offers-new-discount-plans-to-compete-in-weight-loss-drug-market\/","url_meta":{"origin":96912,"position":1},"title":"Wegovy Maker Offers New Discount Plans to Compete in Weight Loss Drug Market","author":"Admin","date":"March 31, 2026","format":false,"excerpt":"Danish pharmaceutical company Novo Nordisk is rolling out subscription-based pricing for its weight loss medication Wegovy, offering discounts up to 29% for patients who pay out of pocket. The move comes as the company battles competitor Eli Lilly for market share in the rapidly growing obesity treatment sector.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1774959774994.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":27102,"url":"https:\/\/tvdelmarva.com\/wp\/danish-pharma-giant-strikes-2-1b-deal-for-new-oral-weight-loss-medications\/","url_meta":{"origin":96912,"position":2},"title":"Danish Pharma Giant Strikes $2.1B Deal for New Oral Weight Loss Medications","author":"Admin","date":"February 25, 2026","format":false,"excerpt":"Novo Nordisk has entered a partnership worth up to $2.1 billion with U.S. company Vivtex to create pill versions of obesity and diabetes treatments. The collaboration aims to transform injectable medications into oral drugs using advanced delivery technology.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1772028044719.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":48330,"url":"https:\/\/tvdelmarva.com\/wp\/pharmaceutical-giant-introduces-stronger-version-of-popular-weight-loss-medication\/","url_meta":{"origin":96912,"position":3},"title":"Pharmaceutical Giant Introduces Stronger Version of Popular Weight-Loss Medication","author":"Admin","date":"April 7, 2026","format":false,"excerpt":"Danish pharmaceutical company Novo Nordisk has released a more potent version of its popular weight-loss injection Wegovy across American pharmacies. The new formulation contains 7.2 milligrams compared to the previous maximum dose of 2.4 mg, and will cost patients $399 monthly without insurance.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/04\/news-1775564544995.jpg?fit=450%2C328&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":32896,"url":"https:\/\/tvdelmarva.com\/wp\/wegovy-maker-novo-nordisk-partners-with-hims-hers-after-legal-fight\/","url_meta":{"origin":96912,"position":4},"title":"Wegovy Maker Novo Nordisk Partners with Hims &#038; Hers After Legal Fight","author":"Admin","date":"March 6, 2026","format":false,"excerpt":"Pharmaceutical giant Novo Nordisk and telehealth company Hims & Hers Health have reached an agreement to work together after their recent legal dispute. The partnership will allow weight-loss medications including Wegovy to be sold through the Hims platform.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772846360825.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":25514,"url":"https:\/\/tvdelmarva.com\/wp\/novo-nordisk-stock-crashes-15-after-weight-loss-drug-trial-disappoints\/","url_meta":{"origin":96912,"position":5},"title":"Novo Nordisk Stock Crashes 15% After Weight Loss Drug Trial Disappoints","author":"Admin","date":"February 23, 2026","format":false,"excerpt":"Danish pharmaceutical giant Novo Nordisk saw its stock price plummet more than 15% Monday after announcing its experimental obesity medication CagriSema failed to match competitor Eli Lilly's drug in clinical trials. The disappointing results erased all stock gains the company had made since launching its popular weight loss drug Wegovy.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771849090565.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/96912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=96912"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/96912\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/96911"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=96912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=96912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=96912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}